Radiotherapy, Temozolomide, and Antiprogrammed Cell Death Protein 1 Treatments Modulate the Immune Microenvironment in Experimental High-Grade Glioma. Issue 2 (13th January 2021)

Record Type:: Journal Article
Title:: Radiotherapy, Temozolomide, and Antiprogrammed Cell Death Protein 1 Treatments Modulate the Immune Microenvironment in Experimental High-Grade Glioma. Issue 2 (13th January 2021)
Main Title:: Radiotherapy, Temozolomide, and Antiprogrammed Cell Death Protein 1 Treatments Modulate the Immune Microenvironment in Experimental High-Grade Glioma
Authors:: Riva, Matteo
Wouters, Roxanne
Sterpin, Edmond
Giovannoni, Roberto
Boon, Louis
Himmelreich, Uwe
Gsell, Willy
Van Ranst, Marc
Coosemans, An
Abstract:
Is Part Of:: Neurosurgery. Volume 88:Issue 2(2021)
Journal:: Neurosurgery
Issue:: Volume 88:Issue 2(2021)
Issue Display:: Volume 88, Issue 2 (2021)
Year:: 2021
Volume:: 88
Issue:: 2
Issue Sort Value:: 2021-0088-0002-0000
Page Start:
Page End:
Publication Date:: 2021-01-13
Subjects:: High-grade glioma -- Glioblastoma -- Combination therapies -- Immunotherapy -- PD1 -- Temozolomide -- Stereotactic radiotherapy
Nervous system -- Surgery -- Periodicals
617.48005
Journal URLs:: https://academic.oup.com/neurosurgery ↗
http://www.neurosurgery-online.com ↗
https://journals.lww.com/neurosurgery/pages/default.aspx ↗
http://journals.lww.com ↗
DOI:: 10.1093/neuros/nyaa421 ↗
Languages:: English
ISSNs:: 0148-396X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 6081.582000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 25583.xml